EUVIMEDEUVIMED entdecken
Crossref

Eupatilin suppresses osteoclastogenesis and periodontal bone loss by inhibiting the MAPKs/Siglec-15 pathway

Boxuan Zhao, Zhiyong Chen, Ting Li, Hantao Yao, Zijun Wang, Yilin Liao, Haiying Guo, Dongjie Fu, Yaoting Ji, Minquan Du

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112720 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Boxuan Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Lab…. Hauptthemen laut MEDLINE: Osteogenesis, Flavonoids, Alveolar Bone Loss, Osteoclasts. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Periodontitis is a widely prevalent oral disease around the world characterized by the disruption of the periodontal ligament and the subsequent development of periodontal pockets, as well as the loss of alveolar bone, and may eventually lead to tooth loss. This research aims to assess the suppressive impact of Eupatilin, a flavone obtained from Artemisia argyi, on osteoclastogenesis in vitro and periodontitis in vivo. We found that Eupatilin can efficiently obstruct the differentiation of Raw264.7 and bone marrow-derived macrophages (BMDMs) induced by RANKL, leading to the formation of mature osteoclasts. Consistently, bone slice resorption assay showed that Eupatilin significantly inhibited osteoclast-mediated bone resorption in a dose-dependent manner. Eupatilin also downregulated the expression of osteoclast-specific genes and proteins in Raw264.7 and BMDMs. RNA sequencing showed that Eupatilin notably downregulated the expression of Siglec-15. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses identified significantly enriched pathways in DEGs, including MAPK signaling pathway. And further mechanistic investigations confirmed that Eupatilin repressed MAPKs/NF-κBsignaling pathways. It was found that Siglec-15 overexpression reversed the inhibitory impact of Eupatilin on the differentiation of osteoclasts. Furthermore, activating MAPK signaling pathway reversed the downregulation of Siglec-15 and the inhibition of osteoclastogenesis by Eupatilin. To sum up, Eupatilin reduced the expression of Siglec-15 by suppressing MAPK signaling pathway, ultimately leading to the inhibition of osteoclastogenesis. Meanwhile, Eupatilin suppressed the alveolar bone resorption caused by experimentalperiodontitis in vivo. Eupatilin exhibits potential therapeutic effects in the treatment of periodontitis, rendering it a promising pharmaceutical agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteogenesisFlavonoidsAlveolar Bone LossOsteoclastsPeriodontitisAnimalsMiceRAW 264.7 CellsMice, Inbred C57BLCell DifferentiationMaleMacrophagesMAP Kinase Signaling SystemSignal TransductionArtemisiaRANK Ligand

Stichwörter der Autor:innen

EupatilinMAPKOsteoclastogenesisPeriodontitisSiglec-15

Substanzen

eupatilinFlavonoidsRANK Ligand

Autor:innen und Institutionen

  • State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan Univer…
  • Department of Stomatology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Zhao, B., Chen, Z., Li, T., Yao, H., Wang, Z., Liao, Y., Guo, H., Fu, D., Ji, Y., & Du, M. (2024). Eupatilin suppresses osteoclastogenesis and periodontal bone loss by inhibiting the MAPKs/Siglec-15 pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112720

Vancouver

Zhao B, Chen Z, Li T, Yao H, Wang Z, Liao Y, et al. Eupatilin suppresses osteoclastogenesis and periodontal bone loss by inhibiting the MAPKs/Siglec-15 pathway. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112720

BibTeX
@article{Zhao2024,
  author = {Zhao, Boxuan and Chen, Zhiyong and Li, Ting and Yao, Hantao and Wang, Zijun and Liao, Yilin and Guo, Haiying and Fu, Dongjie and Ji, Yaoting and Du, Minquan},
  title = {Eupatilin suppresses osteoclastogenesis and periodontal bone loss by inhibiting the MAPKs/Siglec-15 pathway},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112720}
}
Kostenlos starten →